Nowadays, with the rise of the incidence of chronic diseases and infectious diseases, the improvement of the awareness of ordinary human subjects and the improvement of the level of medical insurance, the demand for medical devices is increasing. The "Blue Book of China's Medical Device Industry Development Status 2013" (hereinafter referred to as the Blue Book) published by the China Pharmaceutical Materials Association shows that in the past 12 years, the sales volume of China's medical device market has increased from 17.9 billion yuan in 2001 to 170 billion yuan in 2012. The year has increased by 8.5 times. According to the China Medical Device Trade Report for the First Half of 2014 published by the China Chamber of Commerce for Import and Export of Medicines and Health Products, in the first half of 2014, the total import and export volume of medical equipment trade in China was US$16.79 billion, a year-on-year increase of 6.1%. However, it is worth noting that China's exports of hundreds of millions of dollars of products are still concentrated in massage appliances, medical catheters, cotton and other disposable supplies and low-end diagnostic equipment. And high-end medical equipment , China's current dependence on imported products is more serious. The "Blue Book" shows that domestic high-end medical device imports account for about 40% of the total market, about 80% of the CT market, 90% of the ultrasonic instrument market, 85% of the test instrument market, 90% of the magnetic resonance equipment market, 90 % of the ECG market, 80% of the mid-to-high-end monitor market, 90% of the high-end physiological recorder market, and 60% of the sleep charter market are occupied by foreign brands. According to the "Enterprise Observer" report, the three companies, General Motors (GE), Philips, and Siemens, which are referred to as "GPS", have long controlled 70% of the high-end medical equipment market in China. At present, the high cost of inspection is an important reason for expensive medical treatment, which has a lot to do with the high price of imported equipment. "Blue Book" pointed out that the price of imported medical equipment in China is generally 50% to 100% higher than the price of the country of origin such as Europe, America and Japan. For example, the equipment such as TOMO radiation therapy system is more than 2.5 million US dollars in Europe, America and other countries. It is more than 5 million US dollars. Prospective network analyst Li Peijuan pointed out in the research report that the existence of concentrated monopolistic behavior by operators will cause price monopoly to a certain extent. The reason for the high price of imported medical equipment is that there are many intermediate distribution links, and the price is increased at different levels. In addition, the existence of gray trading in equipment procurement has also pushed up prices. A digital subtraction angiography equipment industry practitioner said in an interview with China United Daily News that the profit margin of these devices is as high as 50% to 60%, of which rebates may account for 20%. Under such circumstances, many hospitals still spend a lot of money to purchase imported equipment, which raises the price objectively and also makes the survival of domestic high-end medical equipment difficult. According to the report of the Medical Devices Branch of China Medical Materials Association, as of the end of 2012, there were 14,928 medical device manufacturers in China, and the scale of domestic enterprises was small and the market was scattered. In the first half of 2013, the income of 22 medical device listed companies was only 10 billion yuan. It only accounts for about 5% of the total size of the industry. At the same time, foreign medical device companies are constantly acquiring similar companies with outstanding domestic performance. Adhesive Foam Dressing,Optifoam Dressing,Biatain Foam,Biatain Foam Dressing Roosin Medical Co.,Ltd , https://www.roosinmedical.com